Frankenfield Christopher James
Chief Financial Officer
CIK: 1988344
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Xilio Therapeutics, Inc. (XLO) | S | 7,030 | $0.64 | $4,521.70 | View Details Filing |
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Xilio Therapeutics, Inc. (XLO) | S | 7,030 | $0.64 | $4,521.70 | View Details Filing |